Ardelyx Analyst Ratings
Citi Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $10
Scotiabank Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $15
BTIG Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $14
Ardelyx Downgraded at Raymond James After Q1 Sales Miss
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Arvinas Holding Company (ARVN) and Ardelyx (ARDX)
Raymond James Downgrades Ardelyx to Outperform From Strong Buy, Adjusts Price Target to $11 From $13
Scotiabank Remains a Buy on Ardelyx (ARDX)
TD Cowen Maintains Ardelyx(ARDX.US) With Buy Rating, Cuts Target Price to $10
Ardelyx's Growth Potential and Strategic Efforts Justify Buy Rating Despite Recent Setbacks
Piper Sandler Initiates Ardelyx(ARDX.US) With Hold Rating, Announces Target Price $8
Piper Sandler Sticks to Their Hold Rating for Ardelyx (ARDX)
Vistra, Ardelyx, Zscaler, Lexicon, Arista: Trending by Analysts
Ardelyx Price Target Announced at $15.00/Share by Scotiabank
Ardelyx Initiated at Sector Outperform by Scotiabank
Ardelyx Analyst Ratings
Ladenburg Thalmann Initiates Ardelyx(ARDX.US) With Buy Rating, Announces Target Price $11
BTIG Initiates Ardelyx(ARDX.US) With Buy Rating, Announces Target Price $14
BTIG Initiates Ardelyx at Buy With $14 Price Target
Ardelyx Initiated With a Buy at BTIG